雜志介紹

Journal Of Muscle Research And Cell Motility雜志介紹

《Journal Of Muscle Research And Cell Motility》是一本以English為主的未開放獲取國際優秀期刊，中文名稱肌肉研究與細胞運動雜志，本刊主要出版、報道生物學-CELL BIOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為1.8，最新CiteScore 指數為6.2。

本刊近期中國學者發表的論文主要有：

• Specific effects of neuregulin-1β on the communication between DRG neurons and skeletal muscle cells in vitro

  Author: Menglin Cong, Jianmin Li, Yuan Qiao, Rui Jing, Hao Li, Zhenzhong Li

• Introducing a special edition of the Journal of Muscle Research and Cell Motility on tropomyosin: form and function

  Author: Steven Marston, Matthias Gautel

• A re-interpretation of the rate of tension redevelopment ( kTR) in active muscle

  Author: Li Wang, Masataka Kawai

• A rat model study of atrophy of denervated musculature of the hand being faster than that of denervated muscles of the arm

  Author: Ji-xin Wu, Liang Chen, Fei Ding, Yu-dong Gu

英文介紹

Journal Of Muscle Research And Cell Motility雜志英文介紹

The Journal of Muscle Research and Cell Motility has as its main aim the publication of original research which bears on either the excitation and contraction of muscle, the analysis of any one of the processes involved therein, the processes underlying contractility and motility of animal and plant cells, the toxicology and pharmacology related to contractility, or the formation, dynamics and turnover of contractile structures in muscle and non-muscle cells. Studies describing the impact of pathogenic mutations in genes encoding components of contractile structures in humans or animals are welcome, provided they offer mechanistic insight into the disease process or the underlying gene function. The policy of the Journal is to encourage any form of novel practical study whatever its specialist interest, as long as it falls within this broad field. Theoretical essays are welcome provided that they are concise and suggest practical ways in which they may be tested. Manuscripts reporting new mutations in known disease genes without validation and mechanistic insight will not be considered. It is the policy of the journal that cells lines, hybridomas and DNA clones should be made available by the developers to any qualified investigator. Submission of a manuscript for publication constitutes an agreement of the authors to abide by this principle.